NCT03847610View on ClinicalTrials.gov

Minimally Invasive Sensing of Beta-lactam Antibiotics

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 12, 2018

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Phenoxymethyl Penicillin

Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study

DEVICE

Microneedle array

The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.

Trial Locations (1)

W12 0HS

NIHR Imperial CRF, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT03847610 - Minimally Invasive Sensing of Beta-lactam Antibiotics | Biotech Hunter | Biotech Hunter